Does PEGVISOMANT Cause Lipodystrophy acquired? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Lipodystrophy acquired have been filed in association with PEGVISOMANT (SOMAVERT). This represents 0.3% of all adverse event reports for PEGVISOMANT.
10
Reports of Lipodystrophy acquired with PEGVISOMANT
0.3%
of all PEGVISOMANT reports
0
Deaths
0
Hospitalizations
How Dangerous Is Lipodystrophy acquired From PEGVISOMANT?
Of the 10 reports.
Is Lipodystrophy acquired Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGVISOMANT. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does PEGVISOMANT Cause?
Off label use (460)
Drug ineffective (328)
Insulin-like growth factor increased (320)
Product dose omission issue (255)
Headache (244)
Fatigue (224)
Arthralgia (184)
Death (162)
Injection site pain (161)
Product use issue (158)
What Other Drugs Cause Lipodystrophy acquired?
LAMIVUDINE (383)
ZIDOVUDINE (313)
NEVIRAPINE (288)
STAVUDINE (283)
RITONAVIR (254)
LOPINAVIR\RITONAVIR (230)
DIDANOSINE (216)
TENOFOVIR DISOPROXIL (205)
EFAVIRENZ (203)
INDINAVIR (195)
Which PEGVISOMANT Alternatives Have Lower Lipodystrophy acquired Risk?
PEGVISOMANT vs PEGZEREPOETIN ALFA
PEGVISOMANT vs PEMBROLIZUMAB
PEGVISOMANT vs PEMETREXED
PEGVISOMANT vs PEMIGATINIB
PEGVISOMANT vs PENICILLAMINE